Open AccessTwo Years of Growth Hormone Treatment in Adults With Prader-Willi Syndrome Do Not Improve the Low BMD
Author(s) -
Anders Palmstrøm Jørgensen,
Thor Ueland,
Rasmus Sode-Carlsen,
Thomas Schreiner,
Kai Fr. Rabben,
Stense Farholt,
Charlotte Höybye,
J. S. Christiansen,
Jens Bollerslev
Publication year - 2013
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2012-3378
Subject(s) - medicine , endocrinology , bone mineral , bone remodeling , placebo , bone density , bone resorption , growth hormone treatment , prospective cohort study , osteoporosis , growth hormone , hormone , alternative medicine , pathology
Bone mineral density (BMD) in adult patients with Prader-Willi syndrome (PWS) might be low due to high bone turnover.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom